Category Law & Policy
Conflicts of Interest: The case of Diclectin
Naila Ramji advocates for the importance of clinical trial transparency.
Genome-Edited Babies – A Cause for Concern
Shawn H.E. Harmon describes significant concerns with human genome editing that illustrate multiple failures of governance.
Don’t remand pregnant people or primary caregivers
Jaime Burnet and Martha Paynter advocate for ending the practice of pre-trial imprisonment of pregnant people, primary caregivers of young children, and primary caregivers of people with disabilities
Genome-Edited Persons will Need Legal Protections
Will Hatfield suggests that, in Canada, persons born from gametes or embryos that have been genetically modified would be members of a new class of humans, and potentially in need of specific legal protections.
Just Price for Drugs: The eleventh hour
Marc-André Gagnon urges modernization and fairness in the pricing of patented drugs in Canada
